| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $373,639 ) |
| 2024 | 2024 | THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 001 | 4 | 4/18/2024 | NON-COMPETING CONTINUATION | $19,666 |
| 2024 | 2024 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 4 | 11/15/2023 | NON-COMPETING CONTINUATION | $353,973 |
|
| Issue Date FY: 2023 ( Subtotal = $385,437 ) |
| 2023 | 2023 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 3 | 11/10/2022 | NON-COMPETING CONTINUATION | $353,974 |
| 2023 | 2023 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 001 | 3 | 3/15/2023 | NON-COMPETING CONTINUATION | $31,463 |
|
| Issue Date FY: 2022 ( Subtotal = $385,437 ) |
| 2022 | 2022 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 001 | 2 | 5/20/2022 | NON-COMPETING CONTINUATION | $31,464 |
| 2022 | 2022 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 2 | 11/22/2021 | NON-COMPETING CONTINUATION | $353,973 |
|
| Issue Date FY: 2021 ( Subtotal = $393,305 ) |
| 2021 | 2021 | UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD UNIT 207 | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 1 | 12/7/2020 | NEW | $393,305 |
|
|